342 related articles for article (PubMed ID: 29428085)
1. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
2. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
3. The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels.
Axelsson E; Ljungvall I; Bhoumik P; Conn LB; Muren E; Ohlsson Å; Olsen LH; Engdahl K; Hagman R; Hanson J; Kryvokhyzha D; Pettersson M; Grenet O; Moggs J; Del Rio-Espinola A; Epe C; Taillon B; Tawari N; Mane S; Hawkins T; Hedhammar Å; Gruet P; Häggström J; Lindblad-Toh K
PLoS Genet; 2021 Sep; 17(9):e1009726. PubMed ID: 34473707
[TBL] [Abstract][Full Text] [Related]
4. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
5. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
Markby GR; Macrae VE; Corcoran BM; Summers KM
BMC Vet Res; 2020 Sep; 16(1):350. PubMed ID: 32967675
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
8. Use of whole genome analysis to identify shared genomic variants across breeds in canine mitral valve disease.
Williams B; Friedenberg SG; Keene BW; Tou SP; DeFrancesco TC; Meurs KM
Hum Genet; 2021 Nov; 140(11):1563-1568. PubMed ID: 34176051
[TBL] [Abstract][Full Text] [Related]
9. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
10. Genetics of canine myxomatous mitral valve disease.
O'Brien MJ; Beijerink NJ; Wade CM
Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
Mead SE; Beijerink NJ; O'Brien M; Wade CM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease.
Meurs KM; Olsen LH; Reimann MJ; Keene BW; Atkins CE; Adin D; Aona B; Condit J; DeFrancesco T; Reina-Doreste Y; Stern JA; Tou S; Ward J; Woodruff K
Pharmacogenet Genomics; 2018 Feb; 28(2):37-40. PubMed ID: 29200408
[TBL] [Abstract][Full Text] [Related]
13. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
[TBL] [Abstract][Full Text] [Related]
14. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
15. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
[TBL] [Abstract][Full Text] [Related]
16. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
17. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
Wesselowski S; Gordon SG; Fries R; Saunders AB; Sykes KT; Vitt J; Boutet B; Häggström J; Kadotani S; Stack J; Barnett BG
J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
[TBL] [Abstract][Full Text] [Related]
18. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH
J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441
[TBL] [Abstract][Full Text] [Related]
19. Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.
Lu CC; Liu MM; Culshaw G; Clinton M; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):23-31. PubMed ID: 25841900
[TBL] [Abstract][Full Text] [Related]
20. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]